University of Hawaii Cancer Research Center
12
3
3
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.3%
1 terminated/withdrawn out of 12 trials
87.5%
+1.0% vs industry average
8%
1 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths
Role: collaborator
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Role: collaborator
The Community Garden Health Block
Role: collaborator
Gut Microbial Metabolites of Apple Polyphenols
Role: collaborator
The Healthy Diet and Lifestyle Study II
Role: collaborator
Adapting a Betel Quid Cessation Program for a High-risk Community in Malaysia and Evaluating Its Effectiveness
Role: collaborator
Pediatric Physical Activity for Children With Cancer
Role: collaborator
Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer
Role: collaborator
Testing the Effectiveness of a Betel Nut Cessation Program
Role: collaborator
Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women
Role: lead
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
Role: collaborator
Goal Setting and Lifestyle
Role: collaborator
All 12 trials loaded